T-cell Lymphoma Video Channel

Explore the latest insights and summaries from experts in T-cell Lymphoma.

Therapeutic Agents

16:27

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Therapeutic Advances in T-Cell Lymphoma in 2024

FEATURING Stefan Barta
  • 314 views
  • March 7, 2024
  • 3
13:57

Basem William

IL-21 Expanded NK Cells + Mogamulizumab for Cutaneous T-Cell Lymphomas or Adult T-Cell Leukemia/Lymphomas

  • 31 views
  • July 11, 2024
  • 1
23:31

UChicago Medicine

Overview of Current and Future Management of CTCL

FEATURING Neha Mehta-Shah
  • 83 views
  • July 22, 2024
  • 2
19:05

UChicago Medicine

Novel Therapeutics for T-Cell Lymphoma: Navigating Regulatory Pitfalls

FEATURING Swaminathan Iyer
  • 71 views
  • July 29, 2024
20:20

UChicago Medicine

Epigenetics in T-cell Lymphoma: From Promise to Practice

FEATURING Enrica Marchi
  • 93 views
  • July 29, 2024
10:07

Yale Cancer Center

FDA Approval of E7777 (Denileukin Diftitox) for R/R CTCL - Summary of Pivotal 302 Study

FEATURING Francine Foss
  • 287 views
  • November 5, 2024
  • 2
19:32

SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Tailoring Therapy for PTCL

FEATURING Jasmine Zain
  • 80 views
  • October 12, 2023
  • 1
16:58

SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Novel Targeted Agents in T-Cell Lymphoma

FEATURING Pier Luigi Zinzani
  • 18 views
  • October 18, 2023
19:10

EADV 2023 Insights

EADV 2023 Insights: Interstitial Fluid Immunophenotyping of Early-Stage Mycosis Fungoides Patients After Chlormethine Treatment

FEATURING Selinde Wind
  • 17 views
  • December 4, 2023
23:26

SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Harnessing the Immune System in Patients With Lymphoma

FEATURING Stephen M. Ansell
  • 28 views
  • November 21, 2023
06:51

Insights from 2023 ASH Annual Meeting

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis

FEATURING Douglas Tremblay
  • 433 views
  • December 13, 2023
  • 1